Clinical Trial Update: Phase 2a Study of PBTZ169 [Phase 2]

View source ↗

Summary

Phase 2a study of PBTZ169 for tuberculosis was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• PBTZ169 (PBTZ169)

Snippet

Sponsor: Nearmedic Plus LLC | Conditions: Tuberculosis | Phase 2 | Status: TERMINATED | Results posted: 2020-03-09